author-photo

Mara Morelli

Novartis

6

Papers

2

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI).

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Impact of Disease Burden in Myelofibrosis Patients: A Sub Analysis from Italian Romei Observational Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Real-World Management of Myelofibrosis with Ruxolitinib: Initial Analysis of an Italian Observational Study (ROMEI)

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)